Hepatitis B vaccine series completion by 18 months in infants without a birth dose. 

JAMA network open. 2026

Incident epilepsy and vaccination status or vaccine aluminum exposure in children under age 4. 

Journal of Pediatrics. 2026

Meningococcal B vaccination patterns across 10 integrated health systems within the Vaccine Safety Datalink, 2015-2023. 

Journal of Pediatrics. 2026

JYNNEOS vaccine safety surveillance in the vaccine safety datalink during the 2022 mpox outbreak in the United States. 

Infection. 2025

Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the Vaccine Safety Datalink. 

Vaccine. 2025

COVID-19 vaccination coverage and factors associated with vaccine uptake among people with HIV. 

JAMA network open. 2024

Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study. 

JMIR public health and surveillance. 2024

Influenza vaccination accuracy among adults: self-report compared with electronic health record data. 

Vaccine. 2024

Mortality risk after COVID-19 vaccination: a self-controlled case series study. 

Vaccine. 2024

Safety of the seasonal influenza vaccine in 2 successive pregnancies. 

JAMA network open. 2024

A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. 

Vaccine. 2023

Association between aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months. 

Academic Pediatrics. 2023

Influenza vaccination among pregnant women: self-report compared with vaccination data from electronic health records, 2018-2020 influenza seasons. 

Public Health Reports. 2023

Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: the contribution of vaccine-related attitudes. 

Preventive Medicine. 2023

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink. 

Vaccine. 2023

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. 

Vaccine. 2022

Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the Vaccine Safety Datalink. 

JAMA network open. 2022

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. 

Vaccine. 2022

Safety of COVID-19 vaccination in United States children ages 5 to 11 years. 

Pediatrics. 2022

16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021. 

MMWR: Morbidity and Mortality Weekly Report. 2021

Association of inadvertent 9-valent human papillomavirus vaccine in pregnancy with spontaneous abortion and adverse birth outcomes. 

JAMA network open. 2021

Surveillance for adverse events after COVID-19 mRNA vaccination. 

JAMA. 2021

Temporal trends in undervaccination: a population-based cohort study. 

American Journal of Preventive Medicine. 2021

The childhood vaccination schedule and the lack of association with type 1 diabetes. 

Pediatrics. 2021

Association between rotavirus vaccination and type 1 diabetes in children. 

JAMA pediatrics. 2020

Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink. 

Obstetrics and Gynecology. 2020

Order of live and inactivated vaccines and risk of non-vaccine-targeted infections in US children 11-23 months of age. 

Pediatric Infectious Disease Journal. 2020

SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020. 

MMWR: Morbidity and Mortality Weekly Report. 2020

Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders. 

Vaccine. 2019

Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age. 

JAMA. 2018

Infant hospitalizations and mortality after maternal vaccination. 

Pediatrics. 2018

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. 

Pharmacoepidemiology and Drug Safety. 2018

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: a Vaccine Safety Datalink study. 

Pharmacoepidemiology and Drug Safety. 2018

Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults. 

BMC Pulmonary Medicine. 2017

Influenza vaccination during pregnancy: influenza seasons 2002-2012, Vaccine Safety Datalink. 

American Journal of Preventive Medicine. 2016

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. 

Vaccine. 2014

Timely versus delayed early childhood vaccination and seizures. 

Pediatrics. 2014

Vaccinations given during pregnancy, 2002-2009: a descriptive study. 

American Journal of Preventive Medicine. 2014

A population-based cohort study of undervaccination in 8 managed care organizations across the United States. 

JAMA pediatrics. 2013

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. 

JAMA pediatrics. 2013

Patterns of care and persistence after incident elevated blood pressure. 

Pediatrics. 2013

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. 

Vaccine. 2013

Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. 

Clinical Infectious Diseases. 2013

Trivalent inactivated influenza vaccine and spontaneous abortion. 

Obstetrics and Gynecology. 2013

Measles-containing vaccines and febrile seizures in children age 4 to 6 years. 

Pediatrics. 2012

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. 

Influenza and other respiratory viruses. 2012

Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. 

Pediatrics. 2012

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. 

Archives of Pediatrics and Adolescent Medicine. 2011

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. 

American Journal of Epidemiology. 2010

Risk of immune hemolytic anemia in children following immunization. 

Vaccine. 2009

Varicella vaccination and ischemic stroke in children: is there an association?. 

Pediatrics. 2009

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. 

Pediatrics. 2008

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. 

JAMA. 2006

Scalable PArtnering Network (SPAN) for Comparative Effectiveness Research (CER): research user interface principles and requirements

2013

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety [review]. 

Vaccine. 2014

White paper on the safety of the childhood immunization schedule

2016